InnoSer’s oncology team possesses experience working with multiple oncology therapy types ranging from novel delivery methods, oncology vaccines, immuno-oncology targets, combination therapy, small molecules, biologics to cell and gene therapy approaches.

InnoSer works with well-published in vitro and in vivo models relevant for multiple indications ranging from hypersensitivity, inflammatory, to autoimmune diseases. Choose InnoSer as your CRO, and you’ll work alongside our study directors who take a collaborative approach for your study.

InnoSer offers an integrated neurology CRO services portfolio spanning from in vitro to in vivo research services. Our experts accelerate your drug development process using in-depth knowledge of the models in our portfolio to provide reliable experimental data. 

InnoSer offers you a portfolio of multiple gold-standard mouse models of common metabolic diseases of different etiologies, ranging from obesity, type 2 diabetes mellitus (T2DM) and their common associated complications such as cognitive dysfunction and/or cardiac dysfunction.

InnoSer, offers gold-standard mouse models for common cardiovascular diseases and heart failure (HFrEF & HFpEF). With expert disease modeling, specialized facilities, and skilled personnel, we ensure reliable cardiac surgeries, technical procedures, and flexible study start-up times for robust data.